查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606267

近距离放射治疗市场：按适应症、产品、剂量类型、最终用户划分 - 2025-2030 年全球预测

Brachytherapy Market by Indication (Breast Cancer, Gynecological Cancer, Prostate Cancer), Offering (Devices, Services), Dosage Type, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年近距离放射治疗市场价值为9.6201亿美元，预计到2024年将达到10.1287亿美元，复合年增长率为5.75%，预计到2030年将达到14.2357亿美元。

近距离放射治疗是体内放射治疗的一种形式，是主要用于癌症的重要治疗方法。这种方法可以精确传递高剂量的辐射，同时最大限度地减少对周围健康组织的暴露。近距离放射治疗的需求是显而易见的，因为与外部束放射相比，近距离放射治疗具有针对性、高效的治疗效果，且治疗时间更短，这使得它对治疗前列腺癌、子宫颈癌、乳癌和皮肤癌至关重要。最终用途包括医院、专门的癌症治疗中心和门诊病人设施。市场成长是由新兴国家的技术进步、癌症发生率增加和医疗基础设施扩大所推动的。在近距离放射治疗中采用影像引导和机器人技术是提高治疗准确性和患者治疗效果的关键成长要素。新的商机在于利用人工智慧和机器学习来製定更个人化的治疗计划并改善放射性崩坏的即时监测。此外，世界日益老化的人口由于对癌症的易感性而呈现出相当大的成长潜力。然而，该市场面临初始设备成本高、监管复杂性以及缺乏接受过近距离放射治疗技术培训的熟练专业人员等限制，这可能会阻碍广泛采用。由于对近距离放射治疗的认识和理解有限，患者也面临焦虑的挑战。创新应侧重于具有成本效益的解决方案和教育计划，以提高医疗保健提供者和患者的认识。研究和开发可以推进到便携式和更紧凑的设备的开发，以使近距离放射治疗可以在偏远和资源有限的地区使用，从而扩大近距离放射治疗的使用范围。此外，与学术机构合作进行先进的放射性同位素研究也是有益的。总体而言，该市场有望实现显着成长，但为了充分发挥其潜力，重要的是透过策略创新和伙伴关係关係克服现有挑战。

主要市场统计
基准年[2023] 96201万美元
预计年份 [2024] 1,012,870,000 美元
预测年份 [2030] 1,423.57 百万美元
复合年增长率（%） 5.75%

市场动态：揭示快速发展的近距离放射治疗市场的关键市场洞察

供给和需求的动态交互作用正在改变近距离放射治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球癌症发生率上升以及有效治疗的需求
    • 以疾病的早期诊断和治疗为目标
    • 人们越来越偏好微创医疗程序
  • 市场限制因素
    • 近距离放射治疗的高成本和复杂性
  • 市场机会
    • 利用个人化医疗方法提供精准治疗
    • 持续研究和开发以提高近距离放射治疗的有效性
  • 市场挑战
    • 严格的法律规范和缺乏熟练的专业人员

波特五力：驾驭近距离放射治疗市场的策略工具

波特五力是了解近距离放射治疗市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解近距离放射治疗市场的外部影响

外部宏观环境因素在塑造近距离放射治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解近距离放射治疗市场的竞争状况

对近距离放射治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵近距离治疗市场供应商的绩效评估

FPNV定位矩阵是评估近距离放射治疗市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了近距离放射治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，近距离放射治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的癌症发生率正在上升，增加了对有效治疗的需求。
      • 疾病的早​​期诊断和治疗趋势
      • 人们对微创医疗程序的兴趣日益浓厚
    • 抑制因素
      • 近距离放射治疗的高成本和复杂性
    • 机会
      • 利用个人化医疗方法提供精准治疗
      • 持续研究和开发以提高近距离放射治疗的有效性
    • 任务
      • 严格的法规结构和缺乏熟练的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章近距离放射治疗市场（依适应症）

  • 乳癌
  • 妇科癌症
  • 摄护腺癌

第七章近距离放射治疗市场：透过提供

  • 装置
    • 后荷机
    • 施用器
    • 种子
  • 服务

第八章按剂量类型分類的近距离放射治疗市场

  • 高剂量率 (HDR) 近距离放射治疗
  • 低剂量率 (LDR) 近距离放射治疗

第 9 章近距离放射治疗市场：依最终用户分类

  • 医院
  • 专科诊所

第10章美洲近距离放射治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区近距离放射治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲近距离放射治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Accuray Incorporated
  • BEBIG Medical GmbH
  • Becton, Dickinson and Company
  • Best Medical International, Inc.
  • BWX Technologies. Inc.
  • CivaTech Oncology Inc.
  • CIVCO Medical Solutions
  • Eckert & Ziegler Radiopharma GmbH
  • Elekta AB
  • GammaTile
  • Healvita Group GmbH
  • Hologic, Inc.
  • iCAD, Inc.
  • IsoAid, LLC
  • Isoray Medical, Inc. by Perspective Therapeutics
  • Mick Radio-Nuclear Instruments, Inc.
  • Mirion Technologies, Inc.
  • Nihon Medi-Physics Co., Ltd.
  • Qfix
  • Theragenics
  • Varian Medical Systems, Inc.
Product Code: MRR-521BAA36EB3B

The Brachytherapy Market was valued at USD 962.01 million in 2023, expected to reach USD 1,012.87 million in 2024, and is projected to grow at a CAGR of 5.75%, to USD 1,423.57 million by 2030.

Brachytherapy, a form of internal radiation therapy, is a critical treatment modality primarily used for cancer, involving placing radioactive material directly within or next to a tumor. This approach allows for high-dose radiation delivery with precision, minimizing exposure to surrounding healthy tissue. The necessity of brachytherapy is evident in its targeted efficiency and reduced treatment times compared to external beam radiation, making it integral in treating prostate, cervical, breast, and skin cancers. The end-use scope extensively covers hospitals, specialized cancer treatment centers, and outpatient facilities. Market growth is driven by technological advancements, increasing cancer prevalence, and expanding healthcare infrastructure in emerging economies. The adoption of image-guided and robotic technologies in brachytherapy is a key growth factor, enhancing treatment accuracy and patient outcomes. Emerging opportunities lie in leveraging AI and machine learning to develop more personalized treatment plans and improve real-time monitoring of radioactive decay. Additionally, the rise in geriatric populations worldwide presents considerable growth potential, given their higher susceptibility to cancer. However, the market faces limitations such as high initial equipment costs, regulatory complexities, and a shortage of skilled professionals trained in brachytherapy techniques, which can hinder adoption. There's also a challenge in patient apprehension due to limited awareness and understanding of brachytherapy. Innovations should focus on cost-effective solutions and educational programs to raise awareness among healthcare providers and patients. Research can expand into developing portable or more compact devices to make brachytherapy accessible in remote and resource-limited areas, thus broadening its reach. Moreover, collaborations with academic institutions for research in advanced radioactive isotopes can prove beneficial. Overall, while the market is poised for substantial growth, overcoming existing challenges through strategic innovations and partnerships will be crucial for capitalizing on its full potential.

KEY MARKET STATISTICS
Base Year [2023] USD 962.01 million
Estimated Year [2024] USD 1,012.87 million
Forecast Year [2030] USD 1,423.57 million
CAGR (%) 5.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Brachytherapy Market

The Brachytherapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cancer worldwide and need for efficient treatment
    • Inclination toward early diagnosis and treatment of diseases
    • Increasing preference for minimally invasive medical procedures
  • Market Restraints
    • High cost and complexity in brachytherapy
  • Market Opportunities
    • Utilization of personalized medicine approach to deliver precise treatment
    • Ongoing R&D to enhance the efficacy of brachytherapy
  • Market Challenges
    • Stringent regulatory framework and dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Brachytherapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Brachytherapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Brachytherapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Brachytherapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Brachytherapy Market

A detailed market share analysis in the Brachytherapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Brachytherapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Brachytherapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Brachytherapy Market

A strategic analysis of the Brachytherapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brachytherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, BEBIG Medical GmbH, Becton, Dickinson and Company, Best Medical International, Inc., BWX Technologies. Inc., CivaTech Oncology Inc., CIVCO Medical Solutions, Eckert & Ziegler Radiopharma GmbH, Elekta AB, GammaTile, Healvita Group GmbH, Hologic, Inc., iCAD, Inc., IsoAid, LLC, Isoray Medical, Inc. by Perspective Therapeutics, Mick Radio-Nuclear Instruments, Inc., Mirion Technologies, Inc., Nihon Medi-Physics Co., Ltd., Qfix, Theragenics, and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Brachytherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Breast Cancer, Gynecological Cancer, and Prostate Cancer.
  • Based on Offering, market is studied across Devices and Services. The Devices is further studied across Afterloaders, Applicators, and Seeds.
  • Based on Dosage Type, market is studied across High-Dose Rate (HDR) Brachytherapy and Low-Dose Rate (LDR) Brachytherapy.
  • Based on End User, market is studied across Hospitals and Specialty Clinic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer worldwide and need for efficient treatment
      • 5.1.1.2. Inclination toward early diagnosis and treatment of diseases
      • 5.1.1.3. Increasing preference for minimally invasive medical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and complexity in brachytherapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Utilization of personalized medicine approach to deliver precise treatment
      • 5.1.3.2. Ongoing R&D to enhance the efficacy of brachytherapy
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory framework and dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Brachytherapy Market, by Indication

  • 6.1. Introduction
  • 6.2. Breast Cancer
  • 6.3. Gynecological Cancer
  • 6.4. Prostate Cancer

7. Brachytherapy Market, by Offering

  • 7.1. Introduction
  • 7.2. Devices
    • 7.2.1. Afterloaders
    • 7.2.2. Applicators
    • 7.2.3. Seeds
  • 7.3. Services

8. Brachytherapy Market, by Dosage Type

  • 8.1. Introduction
  • 8.2. High-Dose Rate (HDR) Brachytherapy
  • 8.3. Low-Dose Rate (LDR) Brachytherapy

9. Brachytherapy Market, by End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Specialty Clinic

10. Americas Brachytherapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Brachytherapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Brachytherapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accuray Incorporated
  • 2. BEBIG Medical GmbH
  • 3. Becton, Dickinson and Company
  • 4. Best Medical International, Inc.
  • 5. BWX Technologies. Inc.
  • 6. CivaTech Oncology Inc.
  • 7. CIVCO Medical Solutions
  • 8. Eckert & Ziegler Radiopharma GmbH
  • 9. Elekta AB
  • 10. GammaTile
  • 11. Healvita Group GmbH
  • 12. Hologic, Inc.
  • 13. iCAD, Inc.
  • 14. IsoAid, LLC
  • 15. Isoray Medical, Inc. by Perspective Therapeutics
  • 16. Mick Radio-Nuclear Instruments, Inc.
  • 17. Mirion Technologies, Inc.
  • 18. Nihon Medi-Physics Co., Ltd.
  • 19. Qfix
  • 20. Theragenics
  • 21. Varian Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. BRACHYTHERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. BRACHYTHERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BRACHYTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BRACHYTHERAPY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BRACHYTHERAPY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BRACHYTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BRACHYTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BRACHYTHERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BRACHYTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BRACHYTHERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BRACHYTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BRACHYTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BRACHYTHERAPY MARKET SIZE, BY APPLICATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SEEDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BRACHYTHERAPY MARKET SIZE, BY HIGH-DOSE RATE (HDR) BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BRACHYTHERAPY MARKET SIZE, BY LOW-DOSE RATE (LDR) BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BRACHYTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. BRACHYTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. BRACHYTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023